Table 1.
Demographic and clinical characteristics by H. pylori eradication groups (n = 69a).
| Variable | Eradication success n = 44 | Eradication failure n = 25 | p-value |
|---|---|---|---|
| Age, mean (±SD) | 46.4 (±14.0) | 49.2 (±14.1) | 0.429 |
| Gender female | 26 (59%) | 18 (72%) | 0.284 |
| University education | 31 (70.5%) | 20 (80%) | 0.385 |
| Alcohol consumption | 13 (29.5%) | 4 (16%) | 0.256 |
| Tobacco use | 11 (25%) | 4 (16%) | 0.290 |
| Pyrosis (+) | 14 (31.8%) | 10 (40%) | 0.493 |
| Dyspepsia (+) | 22 (50%) | 13 (52%) | 0.873 |
| Epigastralgia (+) | 17 (38.6%) | 11 (44%) | 0.663 |
| Esophagus findings | 6 (13.6%) | 6 (24%) | 0.275 |
| Gastric fundus findings: Congestion (+) | 14 (31.8%) | 9 (36%) | 0.723 |
| Gastric corpus findings: Congestion (+) | 20 (45.5%) | 10 (40%) | 0.660 |
| Antral findings: Congestion and/or nodular gastropathy (+)b | 18 (40.9%) | 13 (52%) | 0.373 |
| Duodenal findings: Erosions and ulcers (+) | 12 (27.3%) | 6 (24%) | 0.766 |
| CLA resistance | 5 (11.4%) | 13 (52.0%) | <0.001 |
| Phenotype EM | 34 (61.8%) | 21 (38.2%) | 0.235 |
| Phenotype UM | 1 (33.3%) | 2 (66.7%) | |
| Phenotype IM | 9 (81.8%) | 2 (18.2%) |
aDuring the follow-up four patients dropped their participation in the study.
bNodular gastropathy and congestion were pulled together for analysis. All nodular patients were H. pylori positive by rapid urease test.